← Back to Clinical Trials
Recruiting NCT04107181

NCT04107181 Pilot Study for Speculum Free Cervical Cancer Screening

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04107181
Status Recruiting
Phase —
Sponsor Duke University
Condition Cervical Cancer
Study Type INTERVENTIONAL
Enrollment 305 participants
Start Date 2016-04-14
Primary Completion 2028-02-01

Trial Parameters

Condition Cervical Cancer
Sponsor Duke University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 305
Sex FEMALE
Min Age 21 Years
Max Age 65 Years
Start Date 2016-04-14
Completion 2028-02-01
Interventions
Introducer "calla" deviceInterviews only

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.

Eligibility Criteria

Inclusion Criteria: Healthy female * Aged 21-65 years * Have had a pelvic exam * Have conversational proficiency in English * Highest level of education attained Exclusion Criteria: \- Pregnant women

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

VIEW ON CLINICALTRIALS.GOV ↗ MORE CERVICAL CANCER TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology